Sponsor Dossier
Organon Pharma
Sponsor Dossier for Organon Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANTROQUORIL
- Brand: ARCOXIA
- Brand: ATOZET
- Brand: AVANZA
- Brand: CELESTONE
- Brand: CELESTONE-M
- Brand: COZAAR
- Brand: DIPROSONE
- Device (sponsor): JADA System - Intrauterine haemostatic suction catheter
- Device (sponsor): Applicator, vaginal, single use
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Needle, injector, medication/vaccine
- Device (sponsor): Follicle stimulating hormone pen
About
Organon Pharma is an Australian Private Company with ABN 54637107512, registered in NSW and currently active.
Portfolio
Organon Pharma has 46 brands on the ARTG, of which 41 are indexable and 40 carry a Product Information document. 30 brands are PBS-listed, 9 have a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include ANTROQUORIL, ARCOXIA, ATOZET, AVANZA, CELESTONE, CELESTONE-M, COZAAR, DIPROSONE, ELEUPHRAT, ELOCON, ELONVA, EZALO Composite Pack.
Therapeutic focus
— Cardiology: 16 brands — Reproductive Health: 11 brands — Dermatology: 7 brands — Respiratory: 4 brands — Neurology: 3 brands — Psychiatry: 2 brands — Pain Management: 1 brand — Immunology: 1 brand — Musculoskeletal: 1 brand
PBS footprint
30 brands are PBS-listed, with the latest PBS schedule date 2026-11-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 9 brands with a PBAC outcome on record. The latest AusPAR is 2015-08-25, across 5 brands with an AusPAR on record.